ArticleOncology and therapy2025

Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Talha Munir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.